Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Cervical Cancer

Free Subscription Articles published in Gynecol Oncol Retrieve available abstracts of 160 articles: HTML format

Single Articles

November 2022
1. BRUEGL AS, Emerson J, Tirumala K
   Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?
   Gynecol Oncol. 2022;168:56-61.
   PubMed     Abstract available
   
   
   
2. KNAUSS T, Hansen BT, Pedersen K, Aasbo G, et al
   The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trial.
   Gynecol Oncol. 2022;168:39-47.
   PubMed     Abstract available
   
   
   
3. KA K, Laville A, Rassy E, Ayachi RE, et al
   Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
   Gynecol Oncol. 2022;168:32-38.
   PubMed     Abstract available
   
   
   October 2022
4. PERKINS R, Jeronimo J, Hammer A, Novetsky A, et al
   Comparison of accuracy and reproducibility of colposcopic impression based on a single image versus a two-minute time series of colposcopic images.
   Gynecol Oncol. 2022;167:89-95.
   PubMed     Abstract available
   
   
   
5. CHEN H, Xiong W, Dong X, Liu Y, et al
   Infection status and survival impact of high-risk human papillomavirus in cervical adenocarcinomas: A systematic review and meta-analysis.
   Gynecol Oncol. 2022;167:129-136.
   PubMed     Abstract available
   
   
   September 2022
6. RONSINI C, Kohler C, de Franciscis P, La Verde M, et al
   Laparo-assisted vaginal radical hysterectomy as a safe option for minimal invasive surgery in early stage cervical cancer: A systematic review and meta-analysis.
   Gynecol Oncol. 2022 Sep 20. pii: S0090-8258(22)00580.
   PubMed     Abstract available
   
   
   
7. LEE YW, Morgan JR, Fiascone S, Perkins RB, et al
   Underscreenng, overscreening, and guideline-adherent cervical cancer screening in a national cohort.
   Gynecol Oncol. 2022 Sep 20. pii: S0090-8258(22)01826.
   PubMed     Abstract available
   
   
   
8. PUJADE-LAURAINE E, Tan DSP, Leary A, Mirza MR, et al
   Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.
   Gynecol Oncol. 2022 Sep 9. pii: S0090-8258(22)00552.
   PubMed     Abstract available
   
   
   August 2022
9. KIM Y, Kim SI, Kim H, Lee M, et al
   Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
   Gynecol Oncol. 2022 Aug 12. pii: S0090-8258(22)00541.
   PubMed     Abstract available
   
   
   
10. VAHTERISTO M, Heinavaara S, Anttila A, Sarkeala T, et al
    Alternative cytology triage strategies for primary HPV screening.
    Gynecol Oncol. 2022 Aug 10. pii: S0090-8258(22)00495.
    PubMed     Abstract available
    
    
    July 2022
11. SIVARS L, Hellman K, Crona Guterstam Y, Holzhauser S, et al
    Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer.
    Gynecol Oncol. 2022 Jul 30. pii: S0090-8258(22)00512.
    PubMed     Abstract available
    
    
    
12. ALHOLM Z, He D, Ting J, Zhang YJ, et al
    Real-world treatment drop-off among recurrent or metastatic cervical cancer patients: A US community oncology-based analysis.
    Gynecol Oncol. 2022 Jul 29. pii: S0090-8258(22)00509.
    PubMed     Abstract available
    
    
    
13. BOGANI G, Donato VD, Scambia G, Landoni F, et al
    Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer.
    Gynecol Oncol. 2022 Jul 28. pii: S0090-8258(22)00494.
    PubMed     Abstract available
    
    
    
14. LEITAO MM JR, Zhou QC, Brandt B, Iasonos A, et al
    The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
    Gynecol Oncol. 2022 Jul 22. pii: S0090-8258(22)00434.
    PubMed     Abstract available
    
    
    
15. LI H, Wang S, Liu Y, Wang T, et al
    Prophylactic extended-field irradiation for locally advanced cervical cancer.
    Gynecol Oncol. 2022 Jul 19. pii: S0090-8258(22)00481.
    PubMed     Abstract available
    
    
    
16. CHERSTON C, Yoh K, Huang Y, Melamed A, et al
    Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer.
    Gynecol Oncol. 2022 Jul 1. pii: S0090-8258(22)00427.
    PubMed     Abstract available
    
    
    June 2022
17. SY F, Greuel M, Winkler V, Bussmann H, et al
    Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 Jun 30. pii: S0090-8258(22)00416.
    PubMed     Abstract available
    
    
    
18. ROGOWSKI P, Rottler M, Walter F, Saicic S, et al
    Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Gynecol Oncol. 2022 Jun 25. pii: S0090-8258(22)00423.
    PubMed     Abstract available
    
    
    
19. BACORRO W, Baldivia K, Yu KK, Mariano J, et al
    Outcomes with definitive radiotherapy among patients with locally advanced cervical cancer with relative or absolute contraindications to cisplatin: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 Jun 24. pii: S0090-8258(22)00422.
    PubMed     Abstract available
    
    
    
20. RASMUSSEN CL, Thomsen LT, Baandrup L, Franzmann MB, et al
    Changes in HPV prevalence in Danish women with vulvar cancer during 28 years - A nationwide study of >1300 cancer cases.
    Gynecol Oncol. 2022 Jun 21. pii: S0090-8258(22)00418.
    PubMed     Abstract available
    
    
    
21. SCHIFF JP, Mintz R, Cohen AC, Huang Y, et al
    Overall survival in patients with FIGO stage IVA cervical cancer.
    Gynecol Oncol. 2022 Jun 9. pii: S0090-8258(22)00333.
    PubMed     Abstract available
    
    
    
22. ZHOU N, Cui Y, Zhu R, Kuang Y, et al
    Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo.
    Gynecol Oncol. 2022 Jun 7. pii: S0090-8258(22)00306.
    PubMed     Abstract available
    
    
    
23. HORSBOL TA, Kjaer SK, Andersen EW, Ammitzboll G, et al
    Use of hypnotics among women diagnosed with cervical cancer - A population-based cohort study.
    Gynecol Oncol. 2022 Jun 6. pii: S0090-8258(22)00330.
    PubMed     Abstract available
    
    
    
24. MARTIN AL, Sinha S, Peres LC, Hakam A, et al
    The impact of distance to closest negative margin on survival after pelvic exenteration.
    Gynecol Oncol. 2022;165:514-521.
    PubMed     Abstract available
    
    
    May 2022
25. PIEDIMONTE S, Pond GR, Plante M, Nelson G, et al
    Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study.
    Gynecol Oncol. 2022 May 26. pii: S0090-8258(22)00310.
    PubMed     Abstract available
    
    
    
26. GENNARI P, Tchaikovski S, Meszaros J, Gerken M, et al
    Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer.
    Gynecol Oncol. 2022 May 23. pii: S0090-8258(22)00313.
    PubMed     Abstract available
    
    
    
27. ZHOU S, Liu S, Tian G, Zhao L, et al
    KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer.
    Gynecol Oncol. 2022 May 17. pii: S0090-8258(22)00309.
    PubMed     Abstract available
    
    
    
28. MCKINNISH TR, Greenwade MM, Wilkinson-Ryan I, Schwarz JK, et al
    Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography.
    Gynecol Oncol. 2022 May 7. pii: S0090-8258(22)00259.
    PubMed     Abstract available
    
    
    
29. RONSINI C, Kohler C, De Franciscis P, La Verde M, et al
    Laparo-assisted vaginal radical hysterectomy as a safe option for Minimal Invasive Surgery in early stage cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 May 2. pii: S0090-8258(22)00251.
    PubMed     Abstract available
    
    
    
30. KIM SK, Ursell P, Coleman RL, Monk BJ, et al
    Mitigation and management strategies for ocular events associated with tisotumab vedotin.
    Gynecol Oncol. 2022;165:385-392.
    PubMed     Abstract available
    
    
    April 2022
31. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
    Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act.
    Gynecol Oncol. 2022 Apr 28. pii: S0090-8258(22)00256.
    PubMed     Abstract available
    
    
    
32. JACKSON CG, Moore KN, Cantrell L, Erickson BK, et al
    A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.
    Gynecol Oncol. 2022 Apr 28. pii: S0090-8258(22)00257.
    PubMed     Abstract available
    
    
    
33. XU JY, Chen JN, Lei J, Hu M, et al
    Local treatment improves survival in patients with stage IVB cervical cancer.
    Gynecol Oncol. 2022 Apr 27. pii: S0090-8258(22)00254.
    PubMed     Abstract available
    
    
    
34. TANIGAWA T, Takeshima N, Ishikawa H, Nishio S, et al
    Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
    Gynecol Oncol. 2022 Apr 26. pii: S0090-8258(22)00252.
    PubMed     Abstract available
    
    
    
35. POTHURI B, Eskander RN, Randall LM, O'Malley DM, et al
    Practice changing cervical cancer clinical trials.
    Gynecol Oncol. 2022 Apr 20. pii: S0090-8258(22)00175.
    PubMed    
    
    
    
36. LUHRS O, Bollino M, Ekdahl L, Lonnerfors C, et al
    Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy.
    Gynecol Oncol. 2022 Apr 15. pii: S0090-8258(22)00209.
    PubMed     Abstract available
    
    
    
37. BARRINGTON DA, Riedinger C, Haight PJ, Tubbs C, et al
    Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis.
    Gynecol Oncol. 2022 Apr 11. pii: S0090-8258(22)00213.
    PubMed     Abstract available
    
    
    
38. SAPIENZA LG, Thomas JJ, Showalter TN, Echeverria AE, et al
    Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal.
    Gynecol Oncol. 2022 Apr 8. pii: S0090-8258(22)00208.
    PubMed     Abstract available
    
    
    
39. SAND FL, Frederiksen K, Kjaer SK
    Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins.
    Gynecol Oncol. 2022 Apr 7. pii: S0090-8258(22)00197.
    PubMed     Abstract available
    
    
    
40. SALVO G, Jhingran A, Ramalingam P, Legarreta AF, et al
    Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study.
    Gynecol Oncol. 2022 Apr 5. pii: S0090-8258(22)00204.
    PubMed     Abstract available
    
    
    
41. POLTERAUER S, Reich O, Widschwendter A, Hadjari L, et al
    Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
    Gynecol Oncol. 2022;165:23-29.
    PubMed     Abstract available
    
    
    
42. LIAO X, Xia X, Su W, Yan H, et al
    Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
    Gynecol Oncol. 2022;165:105-113.
    PubMed     Abstract available
    
    
    
43. KASHOFER K, Regauer S, Reich O, Petru E, et al
    Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Gynecol Oncol. 2022;165:121-128.
    PubMed     Abstract available
    
    
    March 2022
44. MOHAMUD A, Hogdall C, Schnack T
    Prognostic value of the 2018 FIGO staging system for cervical cancer.
    Gynecol Oncol. 2022 Mar 25. pii: S0090-8258(22)00127.
    PubMed     Abstract available
    
    
    
45. HACK AP, Zweemer RP, Jonges TN, van der Leij F, et al
    Prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer: A nationwide population-based study.
    Gynecol Oncol. 2022 Mar 14. pii: S0090-8258(22)00177.
    PubMed     Abstract available
    
    
    
46. LEITAO MM JR
    The end of routine lymphadenectomy for the treatment of cervical cancer is rapidly approaching.
    Gynecol Oncol. 2022;164:461-462.
    PubMed    
    
    
    February 2022
47. PH M, Maulard A, Scherier S, Sanson C, et al
    Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review.
    Gynecol Oncol. 2022 Feb 28. pii: S0090-8258(22)00051.
    PubMed     Abstract available
    
    
    
48. GOINS EC, Weber JM, Truong T, Moss HA, et al
    Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database.
    Gynecol Oncol. 2022 Feb 28. pii: S0090-8258(22)00069.
    PubMed     Abstract available
    
    
    
49. KOBAYASHI E, Nakatani E, Tanaka T, Yosuke K, et al
    Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081.
    Gynecol Oncol. 2022 Feb 24. pii: S0090-8258(22)00089.
    PubMed     Abstract available
    
    
    
50. BAETEN IGT, Hoogendam JP, Jonges GN, Jurgenliemk-Schulz IM, et al
    Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
    Gynecol Oncol. 2022 Feb 23. pii: S0090-8258(22)00121.
    PubMed     Abstract available
    
    
    
51. ALGERA MD, van Driel WJ, Slangen BFM, Kruitwagen RFPM, et al
    Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit'.
    Gynecol Oncol. 2022 Feb 22. pii: S0090-8258(22)00123.
    PubMed     Abstract available
    
    
    
52. YAHATA H, Kodama K, Okugawa K, Hachisuga K, et al
    Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer.
    Gynecol Oncol. 2022 Feb 9. pii: S0090-8258(22)00070.
    PubMed     Abstract available
    
    
    January 2022
53. LICHTER KE, Levinson K, Hammer A, Lippitt MH, et al
    Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.
    Gynecol Oncol. 2022 Jan 31. pii: S0090-8258(22)00025.
    PubMed     Abstract available
    
    
    
54. YAN L, Liu Y, Zhang J, Chen X, et al
    In vivo and in vitro study of the potential hazards of surgical smoke during cervical cancer treatment with an ultrasonic scalpel.
    Gynecol Oncol. 2022 Jan 12. pii: S0090-8258(22)00008.
    PubMed     Abstract available
    
    
    
55. MUSA FB, Brouwer E, Ting J, Schwartz NRM, et al
    Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer.
    Gynecol Oncol. 2022 Jan 11. pii: S0090-8258(21)01696.
    PubMed     Abstract available
    
    
    
56. AMPOFO AG, Boyes AW, Khumalo PG, Mackenzie L, et al
    Improving knowledge, attitudes, and uptake of cervical cancer prevention among female students: A systematic review and meta-analysis of school-based health education.
    Gynecol Oncol. 2022 Jan 5. pii: S0090-8258(21)01680.
    PubMed     Abstract available
    
    
    
57. WANG J, Dong J, Zhou Y, Wang K, et al
    Performance of human papillomavirus (HPV) mRNA testing and HPV 16 and 18/45 genotyping combined with age stratification in the triaging of women with ASC-US cytology.
    Gynecol Oncol. 2022 Jan 4. pii: S0090-8258(21)01701.
    PubMed     Abstract available
    
    
    
58. BORCINOVA M, Ragosch V, Jarkovsky J, Bajsova S, et al
    Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study.
    Gynecol Oncol. 2022;164:76-84.
    PubMed     Abstract available
    
    
    December 2021
59. EKDAHL L, Paraghamian S, Eoh KJ, Thumuluru KM, et al
    Long term oncologic and reproductive outcomes after robot-assisted radical trachelectomy for early-stage cervical cancer. An international multicenter study.
    Gynecol Oncol. 2021 Dec 31. pii: S0090-8258(21)01697.
    PubMed     Abstract available
    
    
    
60. CORRIGAN KL, Yoder A, De B, Lin L, et al
    Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.
    Gynecol Oncol. 2021 Dec 30. pii: S0090-8258(21)01690.
    PubMed     Abstract available
    
    
    
61. SPONHOLTZ SE, Ezendam NPM, de Rooij BH, Parner E, et al
    SENTIREC - The sentinel node mapping in women with cervical cancer study - Patient-reported early lymphedema and its impact on quality of life.
    Gynecol Oncol. 2021 Dec 29. pii: S0090-8258(21)01692.
    PubMed     Abstract available
    
    
    
62. KIM SI, Choi BR, Kim HS, Chung HH, et al
    Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approach.
    Gynecol Oncol. 2021 Dec 27. pii: S0090-8258(21)01691.
    PubMed     Abstract available
    
    
    
63. THELISSEN AAB, Jurgenliemk-Schulz IM, van der Leij F, Peters M, et al
    Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2021 Dec 27. pii: S0090-8258(21)01694.
    PubMed     Abstract available
    
    
    
64. CIBULA D, Dostalek L, Jarkovsky J, Mom CH, et al
    Post-recurrence survival in patients with cervical cancer.
    Gynecol Oncol. 2021 Dec 23. pii: S0090-8258(21)01675.
    PubMed     Abstract available
    
    
    
65. GUANI B, Mahiou K, Crestani A, Cibula D, et al
    Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis.
    Gynecol Oncol. 2021 Dec 20. pii: S0090-8258(21)01672.
    PubMed     Abstract available
    
    
    
66. KO EM, Bekelman JE, Hicks-Courant K, Brensinger CM, et al
    Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers.
    Gynecol Oncol. 2021 Dec 20. pii: S0090-8258(21)01627.
    PubMed     Abstract available
    
    
    
67. SHI Y, Chen J, Shi B, Liu A, et al
    Cost-effectiveness analysis of pembrolizumab for treatment of US patients with persistent, recurrent, or metastatic cervical cancer.
    Gynecol Oncol. 2021 Dec 14. pii: S0090-8258(21)01633.
    PubMed     Abstract available
    
    
    
68. SWIFT BE, Maeda A, Bouchard-Fortier G
    Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?
    Gynecol Oncol. 2021 Dec 14. pii: S0090-8258(21)01637.
    PubMed     Abstract available
    
    
    
69. DEBOER RJ, Umutoni V, Bazzett-Matabele L, Katznelson E, et al
    Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
    Gynecol Oncol. 2021 Dec 13. pii: S0090-8258(21)01628.
    PubMed     Abstract available
    
    
    
70. KORENAGA TK, Yoshida EJ, Pierson W, Chang J, et al
    Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
    Gynecol Oncol. 2021 Dec 2. pii: S0090-8258(21)01608.
    PubMed     Abstract available
    
    
    November 2021
71. MANZOUR N, Nunez-Cordoba JM, Chiva L, Chacon E, et al
    Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis.
    Gynecol Oncol. 2021 Nov 27. pii: S0090-8258(21)01623.
    PubMed     Abstract available
    
    
    
72. ARYASOMAYAJULA C, Chanana A, Tandel M, Kwan L, et al
    The role of high-risk HPV testing in cervical cancer surveillance.
    Gynecol Oncol. 2021 Nov 23. pii: S0090-8258(21)01606.
    PubMed     Abstract available
    
    
    
73. HUANG J, Deng Y, Boakye D, Tin MS, et al
    Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysis.
    Gynecol Oncol. 2021 Nov 16. pii: S0090-8258(21)01598.
    PubMed     Abstract available
    
    
    
74. MENG Y, Chu T, Lin S, Wu P, et al
    Clinicopathological characteristics and prognosis of cervical cancer with different histological types: A population-based cohort study.
    Gynecol Oncol. 2021 Nov 2. pii: S0090-8258(21)01451.
    PubMed     Abstract available
    
    
    October 2021
75. CHARGARI C, Arbyn M, Leary A, Abu-Rustum NR, et al
    Increasing global accessibility to high-level treatments for cervical cancers.
    Gynecol Oncol. 2021 Oct 26. pii: S0090-8258(21)01517.
    PubMed     Abstract available
    
    
    
76. BALAYA V, Guani B, Morice P, Querleu D, et al
    Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts.
    Gynecol Oncol. 2021 Oct 22. pii: S0090-8258(21)01518.
    PubMed     Abstract available
    
    
    
77. SHIN W, Park SY, Seo SS, Lim MC, et al
    Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model.
    Gynecol Oncol. 2021 Oct 22. pii: S0090-8258(21)01514.
    PubMed     Abstract available
    
    
    
78. HE WQ, Li C
    Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends.
    Gynecol Oncol. 2021 Oct 20. pii: S0090-8258(21)01519.
    PubMed     Abstract available
    
    
    
79. LEVINSON K, Beavis AL, Purdy C, Rositch AF, et al
    Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538].
    Gynecol Oncol. 2021 Oct 12. pii: S0090-8258(21)01386.
    PubMed    
    
    
    September 2021
80. VAN DER PLAS RCJ, Bos AME, Jurgenliemk-Schulz IM, Gerestein CG, et al
    Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes.
    Gynecol Oncol. 2021 Sep 25. pii: S0090-8258(21)01334.
    PubMed     Abstract available
    
    
    
81. LUHRS O, Ekdahl L, Geppert B, Lonnerfors C, et al
    Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Gynecol Oncol. 2021 Sep 8. pii: S0090-8258(21)01328.
    PubMed     Abstract available
    
    
    
82. QIN J, Shahangian S, Saraiya M, Holt H, et al
    Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
    Gynecol Oncol. 2021 Sep 7. pii: S0090-8258(21)01321.
    PubMed     Abstract available
    
    
    
83. WANG Z, Guo E, Yang B, Xiao R, et al
    Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.
    Gynecol Oncol. 2021 Sep 7. pii: S0090-8258(21)01327.
    PubMed     Abstract available
    
    
    
84. WU S, Ding X, Kong Y, Acharya S, et al
    The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females.
    Gynecol Oncol. 2021 Sep 6. pii: S0090-8258(21)01314.
    PubMed     Abstract available
    
    
    
85. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?
    Gynecol Oncol. 2021 Sep 6. pii: S0090-8258(21)01324.
    PubMed     Abstract available
    
    
    
86. VENKAT P, Salani R
    Changing paradigms in intermediate-risk cervical cancer: Sedlis revisited.
    Gynecol Oncol. 2021;162:527-528.
    PubMed    
    
    
    
87. AO M, Zheng D, Wang J, Gu X, et al
    Risk factors analysis of persistence, progression and recurrence in vaginal intraepithelial neoplasia.
    Gynecol Oncol. 2021;162:584-589.
    PubMed     Abstract available
    
    
    
88. GWACHAM NI, McKenzie ND, Fitzgerald ER, Ahmad S, et al
    Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
    Gynecol Oncol. 2021;162:809-815.
    PubMed     Abstract available
    
    
    August 2021
89. MATZ M, Weir HK, Alkhalawi E, Coleman MP, et al
    Disparities in cervical cancer survival in the United States by race and stage at diagnosis: An analysis of 138,883 women diagnosed between 2001 and 2014 (CONCORD-3).
    Gynecol Oncol. 2021 Aug 25. pii: S0090-8258(21)01312.
    PubMed     Abstract available
    
    
    
90. O'MALLEY DM, Oaknin A, Monk BJ, Selle F, et al
    Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
    Gynecol Oncol. 2021 Aug 24. pii: S0090-8258(21)01316.
    PubMed     Abstract available
    
    
    
91. SALANI R, Liu JF
    The American Society of Clinical Oncology 2021 annual (virtual) meeting: A review and summary of selected abstracts.
    Gynecol Oncol. 2021;162:245-248.
    PubMed    
    
    
    
92. KELTTO N, Leivonen A, Pankakoski M, Sarkeala T, et al
    Cervical testing beyond the screening target age - A register-based cohort study from Finland.
    Gynecol Oncol. 2021;162:315-321.
    PubMed     Abstract available
    
    
    July 2021
93. HRUDA M, Robova H, Rob L, Halaska MJ, et al
    Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Oncological outcomes.
    Gynecol Oncol. 2021 Jul 27. pii: S0090-8258(21)00593.
    PubMed     Abstract available
    
    
    
94. TIWARI R, Narayanan GS, Reddy VP, Vishwanathan B, et al
    Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Gynecol Oncol. 2021 Jul 22. pii: S0090-8258(21)00585.
    PubMed     Abstract available
    
    
    
95. MURAKAMI N, Ando K, Murata M, Murata K, et al
    Why not de-intensification for uterine cervical cancer?
    Gynecol Oncol. 2021 Jul 19. pii: S0090-8258(21)00583.
    PubMed     Abstract available
    
    
    
96. HAESEN J, Salihi R, Van Gorp T, Van Nieuwenhuysen E, et al
    Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
    Gynecol Oncol. 2021 Jul 9. pii: S0090-8258(21)00522.
    PubMed     Abstract available
    
    
    
97. CUZICK J, Du R, Adcock R, Kinney W, et al
    Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
    Gynecol Oncol. 2021 Jul 9. pii: S0090-8258(21)00525.
    PubMed     Abstract available
    
    
    
98. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00512.
    PubMed     Abstract available
    
    
    
99. SALVADO A, Miralpeix E, Sole-Sedeno JM, Kanjou N, et al
    Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00515.
    PubMed     Abstract available
    
    
    June 2021
100. LEVINSON K, Beavis AL, Purdy C, Rositch AF, et al
     Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
     Gynecol Oncol. 2021 Jun 30. pii: S0090-8258(21)00511.
     PubMed     Abstract available
     
     
     
101. CHATZISTAMATIOU K, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, et al
     Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
     Gynecol Oncol. 2021 Jun 28. pii: S0090-8258(21)00516.
     PubMed     Abstract available
     
     
     
102. VAN KEER S, Peeters E, Vanden Broeck D, De Sutter P, et al
     Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
     Gynecol Oncol. 2021 Jun 22. pii: S0090-8258(21)00490.
     PubMed     Abstract available
     
     
     
103. ZHANG G, Zhang Y, He F, Wu H, et al
     Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors.
     Gynecol Oncol. 2021 Jun 17. pii: S0090-8258(21)00492.
     PubMed     Abstract available
     
     
     
104. WAGAR MK, Sobecki JN, Chandereng T, Hartenbach EM, et al
     Postoperative venous thromboembolism in gynecologic oncology patients undergoing minimally invasive surgery: Does modality matter?
     Gynecol Oncol. 2021 Jun 17. pii: S0090-8258(21)00491.
     PubMed     Abstract available
     
     
     
105. BENITO V, Lubrano A, Perez-Regadera JF, Torne A, et al
     Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
     Gynecol Oncol. 2021 Jun 9. pii: S0090-8258(21)00485.
     PubMed     Abstract available
     
     
     
106. RONSINI C, Anchora LP, Restaino S, Fedele C, et al
     The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
     Gynecol Oncol. 2021 Jun 9. pii: S0090-8258(21)00482.
     PubMed     Abstract available
     
     
     
107. MILLS JM, Morgan JR, Dhaliwal A, Perkins RB, et al
     Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
     Gynecol Oncol. 2021 Jun 3. pii: S0090-8258(21)00441.
     PubMed     Abstract available
     
     
     
108. PEI X, Xiang L, Chen W, Jiang W, et al
     The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
     Gynecol Oncol. 2021;161:779-786.
     PubMed     Abstract available
     
     
     May 2021
109. SERT BM, Kristensen GB, Kleppe A, Dorum A, et al
     Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
     Gynecol Oncol. 2021 May 31. pii: S0090-8258(21)00434.
     PubMed     Abstract available
     
     
     
110. BRODEUR MN, Dejean R, Beauchemin MC, Samouelian V, et al
     Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
     Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00429.
     PubMed     Abstract available
     
     
     
111. SONG F, Belinson JL, Yan P, Huang X, et al
     Evaluation of p16(INK4a) immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
     Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00410.
     PubMed     Abstract available
     
     
     
112. ISHIKAWA M, Shibata T, Iwata T, Nishio S, et al
     A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Prim
     Gynecol Oncol. 2021 May 17. pii: S0090-8258(21)00403.
     PubMed     Abstract available
     
     
     
113. MATSUO K, Mandelbaum RS, Klar M, Ciesielski KM, et al
     Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States.
     Gynecol Oncol. 2021 May 12. pii: S0090-8258(21)00364.
     PubMed     Abstract available
     
     
     April 2021
114. DILLEY S, Huh W, Blechter B, Rositch AF, et al
     It's time to re-evaluate cervical Cancer screening after age 65.
     Gynecol Oncol. 2021 Apr 26. pii: S0090-8258(21)00347.
     PubMed     Abstract available
     
     
     
115. FANG C, Zhang P, Yu A, Yang Y, et al
     Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without.
     Gynecol Oncol. 2021 Apr 12. pii: S0090-8258(21)00275.
     PubMed     Abstract available
     
     
     
116. DODD RH, Cvejic E, Bell K, Black K, et al
     Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study.
     Gynecol Oncol. 2021;161:179-187.
     PubMed     Abstract available
     
     
     March 2021
117. MATSUO K, Huang Y, Matsuzaki S, Ragab OM, et al
     Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
     Gynecol Oncol. 2021 Mar 23. pii: S0090-8258(21)00171.
     PubMed     Abstract available
     
     
     
118. CHANG CL, Ho SC, Su YF, Juan YC, et al
     DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
     Gynecol Oncol. 2021 Mar 20. pii: S0090-8258(21)00148.
     PubMed     Abstract available
     
     
     
119. ALHOLM Z, Monk BJ, Ting J, Pulgar S, et al
     Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
     Gynecol Oncol. 2021 Mar 16. pii: S0090-8258(21)00194.
     PubMed     Abstract available
     
     
     
120. KIM J, Cho Y, Kim N, Chung SY, et al
     Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
     Gynecol Oncol. 2021;160:735-741.
     PubMed     Abstract available
     
     
     February 2021
121. SKORSTENGAARD M, Frederiksen ME, Baillet MV, Beau AB, et al
     Cervical cancer survivors and health care use: A Danish population-based register study.
     Gynecol Oncol. 2021 Feb 19. pii: S0090-8258(21)00139.
     PubMed     Abstract available
     
     
     
122. VARELA CAGETTI L, Gonzague-Casabianca L, Zemmour C, Lambaudie E, et al
     The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
     Gynecol Oncol. 2021 Feb 6. pii: S0090-8258(21)00094.
     PubMed     Abstract available
     
     
     
123. BROOKS SE, Davis EC, Farley JH
     Disparities in pap smear screening follow up: A catalyst for collective action vs. collective despair.
     Gynecol Oncol. 2021;160:361-363.
     PubMed    
     
     
     January 2021
124. BOGANI G, Sopracordevole F, Di Donato V, Ciavattini A, et al
     High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes.
     Gynecol Oncol. 2021 Jan 26. pii: S0090-8258(21)00080.
     PubMed     Abstract available
     
     
     
125. CASTLE PE, Locke A, Tergas AI, Befano B, et al
     The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses.
     Gynecol Oncol. 2021 Jan 13. pii: S0090-8258(21)00052.
     PubMed     Abstract available
     
     
     
126. KALJOUW S, Jansen EEL, Aitken CA, Harrijvan LM, et al
     Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study.
     Gynecol Oncol. 2021 Jan 12. pii: S0090-8258(20)34253.
     PubMed     Abstract available
     
     
     
127. KANAO H, Aoki Y, Omi M, Nomura H, et al
     Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
     Gynecol Oncol. 2021 Jan 7. pii: S0090-8258(20)34249.
     PubMed     Abstract available
     
     
     
128. ZAPARDIEL I, Kocian R, Kohler C, Klat J, et al
     Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX.
     Gynecol Oncol. 2021 Jan 5. pii: S0090-8258(20)34221.
     PubMed     Abstract available
     
     
     
129. BOGANI G, Raspagliesi F, di Donato V, Brusadelli C, et al
     Spotlight on the role of human papillomavirus vaccines.
     Gynecol Oncol. 2021;160:346-350.
     PubMed     Abstract available
     
     
     December 2020
130. DAHLMAN D, Li X, Magnusson H, Sundquist J, et al
     Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study.
     Gynecol Oncol. 2020 Dec 31. pii: S0090-8258(20)34214.
     PubMed     Abstract available
     
     
     
131. JOU J, Coulter E, Roberts T, Binder P, et al
     Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation.
     Gynecol Oncol. 2020 Dec 17. pii: S0090-8258(20)34180.
     PubMed     Abstract available
     
     
     
132. FACHINI AMD, Zuliani AC, Sarian LO, Teixeira JC, et al
     Long-term outcomes of concomitant cisplatin plus radiotherapy versus radiotherapy alone in patients with stage IIIB squamous cervical cancer: A randomized controlled trial.
     Gynecol Oncol. 2020 Dec 16. pii: S0090-8258(20)34157.
     PubMed     Abstract available
     
     
     
133. FORD S, Tarraf W, Williams KP, Roman LA, et al
     Differences in cervical cancer screening and follow-up for black and white women in the United States.
     Gynecol Oncol. 2020 Dec 12. pii: S0090-8258(20)34155.
     PubMed     Abstract available
     
     
     
134. PAREEK V, Barthwal M, Giridhar P, Patil PA, et al
     A phase III randomised trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer.
     Gynecol Oncol. 2020 Dec 6. pii: S0090-8258(20)34160.
     PubMed     Abstract available
     
     
     
135. SPINILLO A, Dominoni M, Boschi AC, Cesari S, et al
     The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
     Gynecol Oncol. 2020;159:630-635.
     PubMed     Abstract available
     
     
     
136. COHEN PA, Leung Y, Anderson L, van der Griend R, et al
     Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and
     Gynecol Oncol. 2020;159:623-629.
     PubMed     Abstract available
     
     
     
137. BOGANI G, DI Donato V, Sopracordevole F, Ciavattini A, et al
     Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
     Gynecol Oncol. 2020;159:636-641.
     PubMed     Abstract available
     
     
     November 2020
138. STALEY SA, Tucker KR, Gehrig PA, Clark LH, et al
     Accuracy of preoperative cross-sectional imaging in cervical cancer patients undergoing primary radical surgery.
     Gynecol Oncol. 2020 Nov 16. pii: S0090-8258(20)34067.
     PubMed     Abstract available
     
     
     
139. JANSEN EEL, Ivanus U, Jerman T, de Koning HJ, et al
     The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.
     Gynecol Oncol. 2020 Nov 13. pii: S0090-8258(20)34058.
     PubMed     Abstract available
     
     
     
140. DE LA MOTTE ROUGE T, Touboul C, Lhomel C, Roupret M, et al
     Factors associated with compliance to cervical cancer screening in France: The EDIFICE 6 survey.
     Gynecol Oncol. 2020 Nov 3. pii: S0090-8258(20)34054.
     PubMed     Abstract available
     
     
     
141. BREWSTER WR
     Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality?
     Gynecol Oncol. 2020;159:297-298.
     PubMed    
     
     
     October 2020
142. HAN X, Liu S, Yang G, Hosseinifard H, et al
     Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
     Gynecol Oncol. 2020 Oct 19. pii: S0090-8258(20)34019.
     PubMed     Abstract available
     
     
     
143. HUNG P, Zahnd WE, Brandt HM, Adams SA, et al
     Cervical cancer treatment initiation and survival: The role of residential proximity to cancer care.
     Gynecol Oncol. 2020 Oct 17. pii: S0090-8258(20)34014.
     PubMed     Abstract available
     
     
     
144. KWON BS, Roh HJ, Lee S, Yang J, et al
     Comparison of long-term survival of total abdominal radical hysterectomy and laparoscopy-assisted radical vaginal hysterectomy in patients with early cervical cancer: Korean multicenter, retrospective analysis.
     Gynecol Oncol. 2020 Oct 8. pii: S0090-8258(20)33945.
     PubMed     Abstract available
     
     
     
145. BAO H, Bi H, Zhang X, Zhao Y, et al
     Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
     Gynecol Oncol. 2020;159:171-178.
     PubMed     Abstract available
     
     
     September 2020
146. CHINO J, Annunziata CM, Beriwal S, Bradfield L, et al
     The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
     Gynecol Oncol. 2020 Sep 22. pii: S0090-8258(20)33908.
     PubMed    
     
     
     
147. LANDY R, Mathews C, Robertson M, Wiggins CL, et al
     A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.
     Gynecol Oncol. 2020 Sep 22. pii: S0090-8258(20)33850.
     PubMed     Abstract available
     
     
     
148. LI C, Li X, You J, Liang B, et al
     Impact of radiation source activity on short- and long-term outcomes of cervical carcinoma patients treated with high-dose-rate brachytherapy: A retrospective cohort study.
     Gynecol Oncol. 2020 Sep 12. pii: S0090-8258(20)33854.
     PubMed     Abstract available
     
     
     
149. CAO D, Shen K, Chen Y, Xu Y, et al
     Value of endocervical curettage in follow-up for patients with cervical intraepithelial neoplasia stage 2+ after loop electrosurgical excision.
     Gynecol Oncol. 2020;158:584-589.
     PubMed     Abstract available
     
     
     
150. FRUMOVITZ M, Westin SN, Salvo G, Zarifa A, et al
     Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract.
     Gynecol Oncol. 2020;158:570-575.
     PubMed     Abstract available
     
     
     July 2020
151. HUH WK, Brady WE, Fracasso PM, Dizon DS, et al
     Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
     Gynecol Oncol. 2020 Jul 5. pii: S0090-8258(20)32317.
     PubMed     Abstract available
     
     
     June 2020
152. BONAZZOLI E, Bellone S, Zammataro L, Gnutti B, et al
     Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
     Gynecol Oncol. 2020 Jun 26. pii: S0090-8258(20)32299.
     PubMed     Abstract available
     
     
     
153. VASSEUR D, Lopez J, Croce S, Tondeur G, et al
     Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression.
     Gynecol Oncol. 2020;157:775-782.
     PubMed     Abstract available
     
     
     April 2020
154. GULTEKIN M, Dundar S, Keskinkilic B, Turkyilmaz M, et al
     How to triage HPV positive cases: Results of four million females.
     Gynecol Oncol. 2020 Apr 30. pii: S0090-8258(20)31008.
     PubMed     Abstract available
     
     
     
155. REICH O, Regauer S, Kashofer K
     Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.
     Gynecol Oncol. 2020 Apr 27. pii: S0090-8258(20)30985.
     PubMed     Abstract available
     
     
     February 2020
156. LI X, Xia L, Li J, Chen X, et al
     Reproductive and obstetric outcomes after abdominal radical trachelectomy (ART) for patients with early-stage cervical cancers in Fudan, China.
     Gynecol Oncol. 2020 Feb 28. pii: S0090-8258(20)30152.
     PubMed     Abstract available
     
     
     
157. CHARO LM, Vaida F, Eskander RN, Binder P, et al
     Rapid dissemination of practice-changing information: A longitudinal analysis of real-world rates of minimally invasive radical hysterectomy before and after presentation of the LACC trial.
     Gynecol Oncol. 2020 Feb 17. pii: S0090-8258(20)30154.
     PubMed     Abstract available
     
     
     January 2020
158. MATERN T, Kang E, Lim PC
     Factors in the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma.
     Gynecol Oncol. 2020 Jan 30. pii: S0090-8258(20)30081.
     PubMed     Abstract available
     
     
     
159. TRIMBLE CL, Levinson K, Maldonado L, Donovan MJ, et al
     A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
     Gynecol Oncol. 2020 Jan 28. pii: S0090-8258(19)31865.
     PubMed     Abstract available
     
     
     
160. LI T, Wu Z, Jiang M, Zhao Y, et al
     Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women.
     Gynecol Oncol. 2020 Jan 18. pii: S0090-8258(20)30022.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: